31st International Conference on Nanomedicine and Nanomaterials

Organic, inorganic, and hybrid nanomaterials are the most commonly investigated types of nanomaterials in nanomedicine. Dendrimers, liposomes and exosomes, quantum dots, fullerenes, polymeric micelles, nanoemulsions, RNA nanoparticles, and nanotubes are among the examples. Dendrimers, which have a branched structure, and liposomes, which are similar to lipids, are examples of organic molecules, with each having a feature that helps stop a cancer cell. Drug carriers Nanoparticles (particles less than 100nm in length) outperform standard medications and their delivery techniques in three ways: surface properties, the ability to change the toxicity of active cancer cells, and tumor-specific components. A drug carrier is an inorganic nanoparticle such as gold, silver, or platinum. How does the medication get to the patient? "The electrostatic forces between adjacent molecules aid in the delivery of drug to the tumor site," he explains. Nanomaterials are particularly be

Medicine is evolving. Our goal in our laboratory is to target any new biology that we discover. To accomplish this we are developing a variety of novel modalities. These prospective new medicines differ from traditional small molecules and current large molecules, which are frequently focused at cell surface targets or administered without a specialized molecular-targeting strategy. As a result, sophisticated drug delivery methods are required for the targeted and regulated release of our unique compounds in tissues and cells in order to maximize their potential advantages for patients. Our researchers are dedicated to removing the hurdles that stand between our most promising new medication candidates and their targets in tissues and cells. They are creating a wide spectrum of nanoparticles with the goal of delivering our new modalities to previously unreachable destinations and precisely controlling their release in patient-friendly formulations . They are also looking into new

Nanomedicine   has the potential to have significant social impacts, both positive and negative. Here are some of the ways in which nanomedicine could impact society: Improved health outcomes: Nanomedicine has the potential to significantly improve health outcomes by enabling earlier disease diagnosis, more effective drug delivery, and personalized treatments. This could lead to reduced morbidity and mortality rates, as well as a better quality of life for patients. Increased healthcare access: The improved efficiency and effectiveness of nanomedicine could also lead to increased access to healthcare for people in underserved communities or in developing countries. Nanomedicine could potentially reduce the need for specialized medical equipment and facilities, making healthcare more accessible to those who need it. Ethical concerns: As with any new technology, there are ethical concerns surrounding nanomedicine. For example, the use of nanomedicine could raise questions about pri